H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.2% of adults in Omaha have diagnosed diabetes — 1.8 points below the U.S. 12% figure. Census population 486,051. Nebraska Medicare wound biologics: WPS Government Health Administrators (J5). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Omaha clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Omaha storefront.
Chronic Wound Treatment That Works in Omaha, NE for clinics & physicians. Effective chronic wound treatmen… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 10.2% of adults in Omaha have diagnosed diabetes — 1.8 points below the U.S. 12% figure. Census city-proper population is 486,051. If you are adding chronic wound treatment, start with that epidemiology and with WPS Government Health Administrators (J5) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Chronic Wound Treatment That Works notes (how the product actually works)J5 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Omaha is 10.2% or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, J5 articles mapped. 12% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 10.2% of adults — 1.8 points below the U.S. 12% figure. Obesity is 37.5%; arthritis is 21.4%. That is place-level BRFSS modeling, not a clinic census and not a Omaha trial.
Nebraska is not in CDC’s core Diabetes Belt list, but 12% national prevalence still means diabetic wounds will appear. Stock from your clinic mix, not from belt branding.
No. Hawk Medical LLC is a national distributor founded in 2014. We ship HCT/P 361-compliant tissue, PRP systems, and wound-care biologics to physician practices nationwide, including Nebraska. There is no Omaha storefront or local street address on this page because we are a service-area distributor, not a walk-in clinic.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what J5 reviewers and surveyors expect — not a brochure.
If you operate in Nebraska and another MAC state, say it on the first call. J5 will not port 1:1. We would rather split utilization than watch a sister clinic copy Omaha tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Omaha, NE.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Omaha is J5 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Omaha — 1.8 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Nebraska Part B wound biologics follow this contractor (siblings: IA, KS, MO). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Omaha. Useful for joint-program math; still needs a diagnosis and privileging.
No Omaha storefront. Joe Bradley is an active practice owner. chronic wound treatment stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.